These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7495970)

  • 1. Inhibitor development in haemophiliacs: theoretical background and clinical aspects.
    Sultan Y
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S55-7. PubMed ID: 7495970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs.
    Ehrenforth S; Kreuz W; Scharrer I; Linde R; Funk M; Güngör T; Krackhardt B; Kornhuber B
    Lancet; 1992 Mar; 339(8793):594-8. PubMed ID: 1347102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of hemophilic FVIII inhibitors with FVIII priming, cyclophosphamide immune suppression, and rapid tapering of FVIII immune tolerance.
    Kobrinsky NL; Sjolander DE; Moser DK; Stegman DA
    Am J Hematol; 2004 Jun; 76(2):180-4. PubMed ID: 15164387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product.
    Yee TT; Williams MD; Hill FG; Lee CA; Pasi KJ
    Thromb Haemost; 1997 Sep; 78(3):1027-9. PubMed ID: 9308748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors in mild/moderate haemophilia A: an update.
    Franchini M; Salvagno GL; Lippi G
    Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
    Thom K; Male C; Falger J; Pabinger I
    Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of high responding inhibitors in severe haemophilia A.
    Moschovi M; Aronis S; Trimis G; Platokouki H; Salavoura K; Tzortzatou-Stathopoulou F
    Haemophilia; 2006 Jan; 12(1):95-9. PubMed ID: 16409183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of inhibitor development.
    Reding MT
    Haemophilia; 2006 Dec; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor.
    Ashrani AA; Reding MT; Shet A; Osip J; Humar A; Lake JR; Key NS
    Haemophilia; 2004 Nov; 10(6):735-7. PubMed ID: 15569170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of inhibitors in haemophiliacs. A review of the literature.
    Scharrer I; Neutzling O
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):753-8. PubMed ID: 8292725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.